Specialized news

IVF and PGT-M for Thalassemia: Supporting Hope for Couples Carrying Disease-Causing Variants on Their Journey to a Healthy Pregnancy

When both partners carry genetic variants associated with Thalassemia, the risk of having an affected child depends on the type of Thalassemia, the specific genes and variants carried by each partner, as well as the combination of their genotypes. In particular, given the genetic complexity of the condition, not all couples who “both carry Thalassemia-related variants” have the same level of reproductive risk.

IVF Pregnancies and Preeclampsia Risk: Understanding for Effective Prevention

Ensuring a safe IVF pregnancy with appropriate care and monitoring from the very beginning is crucial for expectant mothers. A proper understanding of risk factors and proactive early screening for preeclampsia enable doctors to effectively guide and manage the pregnancy based on each individual case.

Congratulations on the successful conclusion of the 4th Congress (2026-2031) and the 2026 National Scientific Conference of the Vietnam Society of Sexual Medicine!

On July 25-26, 2026, the 4th Congress (2026-2031) combined with the 2026 National Scientific Conference of the Vietnam Society of Sexual Medicine was successfully held at the Pan Pacific Hotel (1 Thanh Nien Street, Ba Dinh Ward, Hanoi). The event brought together numerous leading experts, doctors, researchers, and representatives from domestic and international scientific organizations, creating a prestigious academic forum to share the latest achievements in the field of sexual medicine and reproductive health.

Congratulations on the successful conclusion of the First Founding Congress of the Ho Chi Minh City Society of Genomic Medicine

On June 20, 2026, at Lecture Hall 3D - Ho Chi Minh City University of Medicine and Pharmacy, the First Founding Congress of the Ho Chi Minh City Society of Genomic Medicine, for the term 2026-2031, was successfully held. This is a significant event for the scientific and medical community, marking a new stage of development for the field of genomic medicine in Ho Chi Minh City in particular and Vietnam in general.

Updates on new advances in preimplantation genetic testing (PGT)

Preimplantation genetic testing (PGT) is becoming an important tool in modern assisted reproductive technology, helping to select genetically healthy embryos before transfer into the uterus. These technological advancements not only improve the effectiveness of IVF but also expand opportunities for many infertile families to have healthy children.

Eurofins GENTIS Updates Newborn Screening Packages

Newborn screening is one of the crucial steps in healthcare that helps detect congenital disorders early in a child's life. Early detection not only allows for early intervention but also helps minimize the risk of complications and limit the impact on physical and intellectual development in the future.

The PGT Testing Process in IVF

PGT (Preimplantation Genetic Testing) is a genetic analysis performed before embryo transfer to help select the best embryos - those without abnormalities in chromosome number or structure, or without disease-causing genetic mutations - for embryo transfer. So, how is the PGT process carried out in IVF treatment?

Eurofins GENTIS provides a comprehensive PGT testing portfolio

Preimplantation Genetic Testing (PGT) is becoming an essential tool for improving IVF success rates and reducing the risk of genetic abnormalities. Eurofins GENTIS offers a comprehensive portfolio of PGT tests, utilizing advanced technologies to support the selection of healthy embryos and optimize the journey to parenthood.